chartexchange

ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited

PR Newswire | Nov 10, 2026 10:09 AM EST

Whether they sold following the November 9, 2026 disclosure or continue to hold their shares, Zura Bio shareholders who suffered losses after the Company announced that its Phase 2 TibuSHIELD trial failed to meet its primary endpoint may be eligible to seek recovery. NEW YORK, Nov. 10,...

Read original article